Auxly Shares Receipt of Dealer’s Licence for Dosecann Facility

Auxly Cannabis Group (TSXV:XLY) announced its subsidiary Dosecann obtained a dealer’s licence for controlled drugs and substances from Health Canada for its 42,000 square foot facility in Charlottetown, P.E.I.

As quoted in the press release:

The Licence allows Dosecann to serve as a central mid-stream hub to Auxly and its subsidiaries and partners in the development and manufacturing of value-added cannabis products. The Licence authorizes Dosecann to engage in various activities related to manufacturing of cannabis oils and resins through extraction of dried cannabis flower, production of authorized cannabis products, product formulation, research and development and quality testing. In addition, the Licence permits the import of input materials and the export of finished cannabis products to international markets for medical and scientific purposes.

Greg Boone, Chief Executive Officer of Dosecann commented: “Receiving our Dealer’s Licence represents the culmination of years’ worth of hard work at the facility to get it prepared for this day and we could not be more excited to see it all coming together. I would like to thank all members of the Dosecann and Auxly teams for their continual efforts and for their commitment to building this world class facility that will act as a key asset within the overall Auxly business strategy.”

Hugo Alves, President and Director of Auxly commented: “Dosecann is the cornerstone asset in our midstream (value-add) business segment and we are thrilled to have received a Dealer’s Licence from Health Canada. We look forward to working closely with Greg and his team as we position Dosecann, and subsequently, Auxly, as a leading producer of value added cannabis products in Canada and beyond.”

Click here to read the full press release.